These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 23207437)
1. Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma. Johnson H; Cohen C; Fatima N; Duncan D; Siddiqui MT Acta Cytol; 2012; 56(6):596-602. PubMed ID: 23207437 [TBL] [Abstract][Full Text] [Related]
2. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid. Liu L; Cohen C; Siddiqui MT Acta Cytol; 2012; 56(4):425-30. PubMed ID: 22846220 [TBL] [Abstract][Full Text] [Related]
3. TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks. Fatima N; Cohen C; Lawson D; Siddiqui MT Cancer Cytopathol; 2011 Apr; 119(2):127-33. PubMed ID: 21287692 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962 [TBL] [Abstract][Full Text] [Related]
5. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens. Kim MJ; Shin HC; Shin KC; Ro JY Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737 [TBL] [Abstract][Full Text] [Related]
6. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Bishop JA; Sharma R; Illei PB Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516 [TBL] [Abstract][Full Text] [Related]
7. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. Turner BM; Cagle PT; Sainz IM; Fukuoka J; Shen SS; Jagirdar J Arch Pathol Lab Med; 2012 Feb; 136(2):163-71. PubMed ID: 22288963 [TBL] [Abstract][Full Text] [Related]
8. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions. Dejmek A; Naucler P; Smedjeback A; Kato H; Maeda M; Yashima K; Maeda J; Hirano T Diagn Cytopathol; 2007 Aug; 35(8):493-7. PubMed ID: 17636482 [TBL] [Abstract][Full Text] [Related]
9. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas. Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392 [TBL] [Abstract][Full Text] [Related]
10. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions. El Hag M; Schmidt L; Roh M; Michael CW Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings. Aikawa E; Kawahara A; Hattori S; Yamaguchi T; Abe H; Taira T; Azuma K; Kage M Cancer Cytopathol; 2011 Oct; 119(5):335-45. PubMed ID: 21717589 [TBL] [Abstract][Full Text] [Related]
12. Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion. Kim JH; Kim YS; Choi YD; Lee JS; Park CS Acta Cytol; 2011; 55(3):266-70. PubMed ID: 21525739 [TBL] [Abstract][Full Text] [Related]
13. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700 [TBL] [Abstract][Full Text] [Related]
14. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis. Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475 [TBL] [Abstract][Full Text] [Related]
15. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung. Brown AF; Sirohi D; Fukuoka J; Cagle PT; Policarpio-Nicolas M; Tacha D; Jagirdar J Arch Pathol Lab Med; 2013 Sep; 137(9):1274-81. PubMed ID: 23289761 [TBL] [Abstract][Full Text] [Related]
16. [Combined detection of thyroid transcription factor 1 and napsin A in pleural fluid cell blocks facilitates cytopathologic diagnosis of pulmonary adenocarcinoma]. Xu X; Liu H; Jiang H; Li C; Yuan S; Yang J Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1610-3. PubMed ID: 26607085 [TBL] [Abstract][Full Text] [Related]
17. The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis. Li L; Li X; Yin J; Song X; Chen X; Feng J; Gao H; Liu L; Wei S PLoS One; 2014; 9(7):e100837. PubMed ID: 25003505 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. Puglisi F; Barbone F; Damante G; Bruckbauer M; Di Lauro V; Beltrami CA; Di Loreto C Mod Pathol; 1999 Mar; 12(3):318-24. PubMed ID: 10102618 [TBL] [Abstract][Full Text] [Related]
19. Unusual expression of thyroid transcription factor 1 and napsin A in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung. An J; Park S; Sung SH; Cho MS; Kim SC Am J Clin Pathol; 2014 May; 141(5):712-7. PubMed ID: 24713744 [TBL] [Abstract][Full Text] [Related]
20. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers. Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]